Royalty Pharma RPRX Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Royalty Pharma's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Royalty Pharma's total costs & expenses?
- Royalty Pharma (RPRX) reported total costs & expenses of $67.54M in Q1 2026.
- How has Royalty Pharma's total costs & expenses changed year-over-year?
- Royalty Pharma's total costs & expenses increased by 98.3% year-over-year, from $34.07M to $67.54M.
- What is the long-term trend for Royalty Pharma's total costs & expenses?
- Over 4 years (2021 to 2025), Royalty Pharma's total costs & expenses has grown at a -1.2% compound annual growth rate (CAGR), from $858.75M to $818.67M.